Replies to post #17449 on Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Dew is that because of the inevitable appeals and the as yet untried antitrust case? Is it possible that the outcome of this case will potentially lead to an alteration in Amphastar's antitrust case strategy the premise of which seems like a stretch? And jog thanks for the timeline update. I suppose some of the time this case is taking is related to administrative necessities like jury selection etc that precede actual trial material presentation. bp